Sluggish European demand and weak respiratory sales raised doubts on Thursday about whether Haleon can meet its sales targets, sending shares in the consumer health company lower despite better-than-expected first-half profit. reut.rs/3S224vureut.rs/3S224vu
British consumer health company Haleon on Thursday reported stronger-than-expected sales growth in North America, its largest market, and robust demand in emerging markets, helping it reaffirm its financial targets. reut.rs/4hFmiFCreut.rs/4hFmiFC
British consumer health company Haleon on Thursday reported stronger-than-expected sales growth in North America, its largest market, and robust demand in emerging markets, helping it reaffirm its financial targets. reut.rs/4g2TZQkreut.rs/4g2TZQk
British Prime Minister Andy Burnham will on Wednesday pledge to overhaul the adult social care system, offering to work with other parties to better fund a service that can cost families hundreds of thousands of pounds. reut.rs/4bNQJpqreut.rs/4bNQJpq
GSK launched a £1.9 billion ($2.52 billion) cost-savings effort on Tuesday to help fund the British drugmaker's expanded late-stage study roster, as CEO Luke Miels works to deliver on his promise of faster drug development. reut.rs/4yM31Zsreut.rs/4yM31Zs